TSS Named a Di Gasell 2025

A person wearing blue gloves and a lab coat is handling a large metal plate, partially immersing it into an industrial liquid tank in a laboratory.
We’re proud to share that TSS has been recognized as a Di Gasell 2025, an award from the national financial newspaper Dagens industri celebrating Sweden’s fastest-growing and most successful companies.

The Di Gasell recognition highlights companies that demonstrate strong, sustainable, and organic growth while maintaining financial stability and a solid business foundation. Each year, only a small percentage of Swedish companies meet the high standards required to become a Gasell.

“This milestone is a testament to our dedication, innovation, and teamwork at TSS. Every one of us has contributed to this achievement, from developing progressive solutions to supporting our customers. It truly shows what we can accomplish together,” says Tobias Holmer, CEO of TSS.

This recognition reflects the continued growth of TSS as a trusted partner in automated temperature monitoring and data-driven compliance for the life science supply chain. It also highlights the collective effort of our teams—driving innovation, delivering customer value, and ensuring product integrity at every stage of the supply chain.

Being named a Di Gasell is more than a financial achievement—it’s a recognition of resilience, collaboration, and purpose. At TSS, we’re proud to grow together with our customers and partners as we continue shaping the future of temperature monitoring.

You may also be interested in

Join us at Clinical Trial Supply Europe 2022

We are glad to announce that we’re exhibiting at the next Clinical Trial Supply Europe conference organized by Arena International.
Read moreDownload Whitepaper
A doctor and patient in a clinical trial consultation.

How to Scale Up Your Clinical Trials

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.
Read moreDownload Whitepaper
Profile photo of Gustaf Rasin, new Chief Operations Officer at TSS.

TSS Welcomes Gustaf Rasin as New Chief Operations Officer

TSS, a prominent provider of temperature monitoring solutions, is delighted to announce the appointment of Gustaf Rasin as its new Chief Operations Officer (COO). Gustaf Rasin will play a vital role in refining the company's operational workflows and fostering its growth and environmental sustainability vision.
Read moreDownload Whitepaper

You may also be interested in

A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read more

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.